1. Inicio
  2. Publicaciones
  3. Experience of targeted Usher exome sequencing as a clinical test.

Experience of targeted Usher exome sequencing as a clinical test.

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Besnard T
  • Baux D
  • Vaché C
  • Faugère V
  • Larrieu L
  • Léonard S
  • Malcolm S
  • Claustres M
  • Roux AF

Grupos

Abstract

We show that massively parallel targeted sequencing of 19 genes provides a new and reliable strategy for molecular diagnosis of Usher syndrome (USH) and nonsyndromic deafness, particularly appropriate for these disorders characterized by a high clinical and genetic heterogeneity and a complex structure of several of the genes involved. A series of 71 patients including Usher patients previously screened by Sanger sequencing plus newly referred patients was studied. Ninety-eight percent of the variants previously identified by Sanger sequencing were found by next-generation sequencing (NGS). NGS proved to be efficient as it offers analysis of all relevant genes which is laborious to reach with Sanger sequencing. Among the 13 newly referred Usher patients, both mutations in the same gene were identified in 77% of cases (10 patients) and one candidate pathogenic variant in two additional patients. This work can be considered as pilot for implementing NGS for genetically heterogeneous diseases in clinical service.

Datos de la publicación

ISSN/ISSNe:
2324-9269,

Molecular genetics & genomic medicine  John Wiley and Sons Inc.

Tipo:
Article
Páginas:
30-43
PubMed:
24498627

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Bioinformatics; NSHL; Usher syndrome; next-generation sequencing; variant prioritization

Compartir